Lexicon Pharmaceuticals Eulerpool Nyheter

Lexicon Pharmaceuticals Eulerpool News

Lexicon Pharmaceuticals Aktiens nyheter

Lexicon Pharmaceuticals bevakas av många journalister och investerare över hela världen. De senaste Lexicon Pharmaceuticals nyheterna samlar vi här.

• 21 juni ·

  Yahoo
  Sector Update: Health Care Stocks Gain in Late Afternoon
• 21 juni ·

  Yahoo
  Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
• 21 juni ·

  Seeking Alpha
  Lexicon resubmits FDA application for sotagliflozin for type 1 diabetes
• 21 juni ·

  TipRanks
  Buy Rating on Lexicon Pharmaceuticals Amid Strong Prospects for Sotagliflozin’s FDA Approval
• 21 juni ·

  Thefly.com
  Lexicon resubmits sotagliflozin NDA for Type 1 Diabetes
• 19 juni ·

  Yahoo
  Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association
• 19 juni ·

  Thefly.com
  Lexicon reports paper on Phase 2 RELIEF-DPN-1 trial published
• 18 juni ·

  Yahoo
  Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
• 18 juni ·

  Thefly.com
  Lexicon announces publication on cost-effectiveness of INPEFA
• 17 juni ·

  Benzinga
  Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session